⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5786620 | 0.54 | — | — | |
| SCHEMBL4354634 | 0.40 | — | — | |
| SCHEMBL6048993 | 0.40 | — | — | |
| SCHEMBL9871570 | 0.35 | — | — | |
| SCHEMBL5610696 | 0.34 | — | — | |
| SCHEMBL433010 | 0.34 | — | — | |
| Strontium SCHEMBL31197911 | 0.32 | — | — | |
| Lindane SCHEMBL75689 | 0.30 | LMNA (1.00) | — | |
| Lindane SCHEMBL10795898 | 0.30 | LMNA (1.00) | — | |
| Lindane SCHEMBL9242537 | 0.30 | LMNA (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5814646-A | TREATING THE PROGRESSION OF ALZHEIMER'S DISEASE, BRAIN DISORDERS | ELI LILLY AND COMPANY (US) | 1998-09-29 | — | — | US | disclosed |